SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001991
Filing Date
2024-11-14
Accepted
2024-11-14 16:30:36
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20240930x10q.htm   iXBRL 10-Q 1114921
2 EX-31.1 nnvc-20240930xex31d1.htm EX-31.1 11012
3 EX-31.2 nnvc-20240930xex31d2.htm EX-31.2 10937
4 EX-32.1 nnvc-20240930xex32d1.htm EX-32.1 6551
5 EX-32.2 nnvc-20240930xex32d2.htm EX-32.2 6722
  Complete submission text file 0001410578-24-001991.txt   5042788

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20240930.xsd EX-101.SCH 42301
7 EX-101.CAL nnvc-20240930_cal.xml EX-101.CAL 29425
8 EX-101.DEF nnvc-20240930_def.xml EX-101.DEF 200792
9 EX-101.LAB nnvc-20240930_lab.xml EX-101.LAB 328435
10 EX-101.PRE nnvc-20240930_pre.xml EX-101.PRE 260900
68 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20240930x10q_htm.xml XML 700758
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 241463130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)